BRCA1 gene mutation associated with neoadjuvant chemotherapy
Tuesday, September 6, 2011 - 21:30
in Health & Medicine
Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) -- the disappearance of all evidence of disease from the breast tissue and lymph nodes -- regardless of disease stage after standard neoadjuvent chemotherapy, according to new research.